Stock News

Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Biktarvy® (Bictegravir, Emtricitabine and Tenofovir Alafenamide) for Treatment of HIV-1 Infection
Biogen Stock Fell Too Far on Unfortunate News
Does Recent Weakness in AbbVie Stock Make It a Buy? 3 Pros, 3 Cons
See what the IHS Markit Score report has to say about Gilead Sciences Inc.
Stocks That Fell to 3-Year Lows in the Week of March 8

As seen on...